Sharp Packaging Services Llc Pharmaceutical Import Profile — United States (DGFT 2022–2026)

Name: Sharp Packaging Services Llc Pharmaceutical Import Records from India — 2 Products, $500.0K FOB USD (DGFT 2022–2026)
Creator: TransData Nexus

Suresh Sormare

Explore

Sharp Packaging Services Llc — Pharmaceutical Importer Profile (2026) | 2 Products, $500.0K Trade | TransData Nexus

Sharp Packaging Services Llc

Pharmaceutical Importer · United States · Corticosteroids Focus · $500.0K Total Trade · DGFT Verified

Sharp Packaging Services Llc is a pharmaceutical importer based in United States with a total trade value of $500.0K across 2 products in 2 therapeutic categories. Based on 10 verified import shipments from Indian Customs (DGFT) records, the company actively imports across multiple product segments. Sharp Packaging Services Llc sources from 1 verified Indian supplier, with Par Formulations Private Limited accounting for 100.0% of imports.

Sharp Packaging Services Llc — Import Portfolio & Supplier Network

Sharp Packaging Services Llc import network — 2 products from Indian suppliers. Source: Indian Customs (DGFT).

Who Are the Verified Indian Suppliers to Sharp Packaging Services Llc?

Customs-verified supplier relationships from Indian DGFT records

Supplier	Value	Shipments	Share
Par Formulations Private Limited	$400.0K	8	100.0%

Sharp Packaging Services Llc sources from 1 verified Indian supplier across 5 distinct formulations. The sourcing is highly concentrated — Par Formulations Private Limited accounts for 100.0% of total imports, indicating a strategic single-source relationship.

Formulation	Value	Ships
Prednisone tablets USP 10 MG (25,000) pono : 4500062459 - po dt : january 27	$100.0K	2
Prednisone tablets USP 5 MG (50,000) pono : 4500062459 - po dt : january 27	$100.0K	2
Methylprednisolone 4MG TAB (50,000) po no : 4500062144 - po dt : december 26	$100.0K	2
Methylprednisolone 4MG TAB (50,000) po no : 4500062459 - po dt : january 27	$50.0K	1
Methylprednisolone 4MG TAB 50 000 pono 4500063013 po dt march 19	$50.0K	1

Import Portfolio — Top 2 by Import Value

#	Product	Category	Value	Ships	Share	Rk
1	Methylprednisolone	Corticosteroids	$300.0K	6	1.0%	6
2	Prednisone	Respiratory	$200.0K	4	0.7%	14

Sharp Packaging Services Llc imports 2 pharmaceutical products across 2 categories into United States totaling $500.0K.

Sharp Packaging Services Llc — Corporate Profile & Information

Company type, headquarters, distribution network, and industry role

1Company Overview

Sharp Packaging Services LLC is a contract packaging and clinical supply chain services provider specializing in the pharmaceutical and biotechnology sectors. Headquartered in Allentown, Pennsylvania, the company offers a comprehensive suite of services, including primary and secondary packaging, labeling, interactive response technologies, logistics, storage, distribution, returns, destruction, analytical and formulation development, insourcing, and comparator sourcing.

Established in 1976, Sharp Packaging Services has grown to become a significant player in the pharmaceutical supply chain, serving clients worldwide. The company operates Good Manufacturing Practice (GMP) certified facilities across the United States, the United Kingdom, Belgium, and the Netherlands, ensuring compliance with stringent regulatory standards.

In May 2020, Sharp expanded its capabilities by acquiring a pharmaceutical packaging facility from Quality Packaging Specialists International, LLC (QPSI) in Macungie, Pennsylvania. This 160,000 square-foot facility offers primary and secondary pharmaceutical packaging services, including bottling, blistering, vial labeling, medical device kitting, and serialization services. The acquisition was part of Sharp's strategy to meet increasing volume demands from clients and to expand its capacity.

2Distribution Network

Sharp Packaging Services operates a robust distribution network with facilities strategically located to serve its clients effectively. The company's headquarters in Allentown, Pennsylvania, serves as a central hub for its operations. Additionally, Sharp has GMP-certified facilities in the United Kingdom, Belgium, and the Netherlands, enabling it to offer global reach and production scalability.

The acquisition of the Macungie facility in May 2020 further enhanced Sharp's logistics capabilities. Located within six miles of the Allentown campus, the Macungie site provides additional capacity and space for expansion, supporting the company's ability to meet increasing volume demands from clients.

3Industry Role

Sharp Packaging Services LLC plays a pivotal role in the pharmaceutical supply chain as a contract packaging and clinical supply chain services provider. The company specializes in offering comprehensive solutions that support the lifecycle of pharmaceutical products, including commercial packaging, clinical services, and sterile manufacturing.

By providing these services, Sharp enables pharmaceutical and biotechnology companies to navigate the complexities of product development, from preclinical stages to commercial launch and beyond. This positions Sharp as a critical intermediary in ensuring the efficient and compliant delivery of pharmaceutical products to the market.

TransData Nexus Research · Company registries, industry databasesMar 2026

Supplier Relationship Intelligence — Sharp Packaging Services Llc

Sourcing concentration, supply chain resilience, and strategic implications

1Sourcing Concentration Analysis

Sharp Packaging Services LLC's sourcing strategy exhibits a high degree of concentration, with a total import value from India amounting to $500,000 USD across 10 shipments. The company's portfolio is entirely focused on two products: Methylprednisolone and Prednisone, imported exclusively from PAR Formulations Private Limited. This single-source dependency indicates a strategic choice to maintain a streamlined supply chain and potentially leverage favorable terms with a key supplier.

However, this concentrated sourcing approach also presents risks. Any disruptions at PAR Formulations Private Limited, such as production issues, regulatory challenges, or geopolitical events, could significantly impact Sharp's ability to meet client demands. The absence of alternative suppliers for these products suggests a need for contingency planning to mitigate potential supply chain disruptions.

2Supply Chain Resilience

The resilience of Sharp Packaging Services LLC's Indian supply chain appears limited due to its reliance on a single supplier, PAR Formulations Private Limited. This dependency means that any operational or regulatory challenges faced by PAR Formulations could directly affect Sharp's supply chain continuity.

The lack of backup suppliers and limited formulation diversity further exacerbate this vulnerability. Additionally, the shipping routes from India to the United States are subject to various risks, including logistical delays, geopolitical tensions, and natural disasters. While PAR Formulations Private Limited is likely to adhere to regulatory compliance standards, the absence of alternative suppliers and limited formulation diversity reduce Sharp's ability to adapt to unforeseen disruptions.

Importing Pharmaceuticals into United States — Regulatory Framework

Regulatory authority, GMP requirements, import licensing for United States

1Regulatory Authority & Framework

In the United States, the Food and Drug Administration (FDA) serves as the primary regulatory authority overseeing the importation and marketing of pharmaceutical products. The FDA enforces the Federal Food, Drug, and Cosmetic Act (FDCA), which sets forth requirements for drug safety, efficacy, and quality. Pharmaceutical imports must comply with FDA regulations, including obtaining appropriate approvals and adhering to Good Manufacturing Practice (GMP) standards.

For Indian pharmaceutical companies seeking to export to the U.S., the FDA requires that manufacturing facilities be registered and that products be approved through the New Drug Application (NDA) or Abbreviated New Drug Application (ANDA) processes. These pathways ensure that imported drugs meet U.S. standards for safety, efficacy, and quality.

2Import Licensing & GMP

Import licensing requirements for pharmaceutical products entering the United States are stringent. Indian exporters must ensure that their manufacturing facilities are registered with the FDA and that their products are approved through the appropriate application processes. Additionally, compliance with GMP standards is mandatory to ensure product quality and safety.

The FDA recognizes various GMP certifications, including those from the European Union (EU GMP), World Health Organization (WHO GMP), and Pharmaceutical Inspection Co-operation Scheme (PIC/S). Indian exporters holding these certifications may find it advantageous when seeking to supply products to U.S. companies like Sharp Packaging Services LLC.

Sharp Packaging Services Llc — Procurement Pattern Analysis

Product strategy, sourcing profile, and market positioning

1Product Strategy

Sharp Packaging Services LLC's focus on importing Methylprednisolone and Prednisone aligns with its strategic emphasis on corticosteroids and respiratory therapeutic categories. These products are commonly used to treat a variety of conditions, including inflammatory and respiratory disorders, indicating a stable market demand.

The concentration on these therapeutic areas suggests that Sharp is catering to specific market needs, potentially leveraging its expertise and operational efficiencies in these segments. This strategy may also reflect a deliberate choice to maintain a specialized product portfolio, reducing complexity and focusing on high-demand products.

2Sourcing Profile

Sharp Packaging Services LLC's sourcing strategy is highly concentrated, importing exclusively from PAR Formulations Private Limited in India. This approach indicates a preference for streamlined operations and potentially favorable terms with a key supplier. The focus on finished pharmaceutical formulations, rather than raw active pharmaceutical ingredients (APIs), suggests a strategy centered on ready-to-market products that require minimal additional processing.

India's established pharmaceutical manufacturing capabilities, including adherence to international GMP standards, make it a suitable partner for Sharp's sourcing needs. However, the lack of supplier diversification may pose risks, as any disruptions at PAR Formulations could impact Sharp's ability to meet client demands.

Seller's Guide — How to Become a Supplier to Sharp Packaging Services Llc

Opportunity assessment, qualifications, and practical approach strategy

1Opportunity Assessment

There is a realistic opportunity for new Indian

TransData Nexus Research · Industry procurement practicesMar 2026

Frequently Asked Questions — Sharp Packaging Services Llc

What products does Sharp Packaging Services Llc import from India?

Sharp Packaging Services Llc imports 2 pharmaceutical products across 2 categories. Top imports: Methylprednisolone ($300.0K), Prednisone ($200.0K).

Who supplies pharmaceuticals to Sharp Packaging Services Llc from India?

Sharp Packaging Services Llc sources from 1 verified Indian suppliers. The primary supplier is Par Formulations Private Limited (100.0% of imports, $400.0K).

What is Sharp Packaging Services Llc's total pharmaceutical import value?

Sharp Packaging Services Llc's total pharmaceutical import value from India is $500.0K, based on 10 verified shipments in Indian Customs (DGFT) data.

What therapeutic categories does Sharp Packaging Services Llc focus on?

Sharp Packaging Services Llc imports across 2 categories. The largest: Corticosteroids (60.0%), Respiratory (40.0%).

Get Full Sharp Packaging Services Llc Import Intelligence

Access shipment-level details, supplier connections, pricing data, and competitive analysis. TransData Nexus provides verified Indian Customs (DGFT) data trusted by pharmaceutical trade professionals worldwide.

Contact for Data Access Request Live Demo

Official References & Regulatory Resources

Verify import regulations and drug registration requirements with the agencies above.

Research Methodology & Data Transparency

Suresh Sormare

Verified Author

Pharmaceutical Export-Import Analyst & Trade Intelligence Expert

Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.

linkedin.com/in/sureshsormare

Primary Data Source

All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.

Data Source & Methodology

Trade data sourced from Indian Customs (DGFT) export shipment records. Values represent FOB export value in USD. For current shipment-level data, contact TransData Nexus.

Sharp Packaging Services Llc

Sharp Packaging Services Llc — Import Portfolio & Supplier Network

Who Are the Verified Indian Suppliers to Sharp Packaging Services Llc?

What Formulations Does Sharp Packaging Services Llc Import?

What Products Does Sharp Packaging Services Llc Import?

Top Products by Import Value

Sharp Packaging Services Llc Therapeutic Categories — 2 Specializations